Companies: 10,793     total market cap: NZ$238.267 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Invesco Biotechnology & Genome ETF
PBE
#2081
ETF rank
NZ$0.42 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$135.90
Share price
-0.50%
Change (1 day)
31.81%
Change (1 year)
๐Ÿงฌ Biotech ETFs
Categories

Expense ratio and fees for Invesco Biotechnology & Genome ETF (PBE)

Expense Ratio

Expense Ratio as of October 2025: 0.58%

Management Fee

Management Fee as of October 2025: 0.5%

Total Expense Ratio

Total Expense Ratio as of April 2026: 0.58%

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com